Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06859242 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Risk Prediction Model for Iodinated Contrast Medium Extravasation

Study acronym: RPMICME
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 5, 2025 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study aims to develop a risk prediction model for iodine contrast agent extravasation from peripheral veins and to implement this model clinically to establish a risk control management system for iodine contrast agent extravasation.A case-control study design was employed to collect data for model development. The case group comprised patients who experienced iodine contrast agent extravasation during enhanced CT examinations, while the control group included patients who underwent similar examinations without extravasation.
Trial Details
NCT Number NCT06859242
Lead Sponsor Zhang Wenyan
Conditions
(from sponsor)		 Extravasation of Contrast Media
Related terms Extravasation of Diagnostic and Therapeutic Materials
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov